Gynecology Surgical Forceps Market Report 2026

Gynecology Surgical Forceps Market Overview

• Gynecology Surgical Forceps market size has reached to $12.95 billion in 2025 • Expected to grow to $17.44 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Rising Incidence Of Uterine And Vaginal Cancer Driving Growth In The Gynecology Surgical Forceps Market • Market Trend: Value-Driven Surgical Instruments Enhance Affordability And Precision • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gynecology Surgical Forceps Market?

Gynecology surgical forceps are specialized instruments used in gynecological procedures to grasp, hold, manipulate, or remove tissue and other materials. They come in various shapes and sizes and are designed for specific tasks such as clamping blood vessels, handling delicate tissues, or retrieving objects. The main types of gynecology surgical forceps include allis forceps, artery forceps, and others. Allis forceps are surgical instruments with toothed ends used for grasping and holding tissues during gynecology surgical procedures such as hysterectomies and pelvic surgeries. The applications include laparoscopy, hysteroscopy, dilation and curettage, colposcopy, and others, and end users include hospitals, ambulatory surgical centers, and others.

What Is The Gynecology Surgical Forceps Market Growth Forecast?

The gynecology surgical forceps market size is expected to see strong growth in the next few years. It will grow to $17.44 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growth in minimally invasive gynecological procedures, rising outpatient and day-care surgeries, increasing investments in women’s health services, expansion of ambulatory surgical centers, growing demand for cost-effective surgical instruments. Major trends in the forecast period include growing adoption of minimally invasive gynecological procedures, rising demand for high-precision and ergonomic surgical instruments, increasing preference for reusable and sterilizable forceps, expansion of gynecological surgical volumes in ambulatory settings, rising focus on infection control and surgical safety.

Global Gynecology Surgical Forceps Market Segmentation

1) By Type: Allis Forceps, Artery Forceps, Other Types 2) By Application: Gynecologic Laparoscopic Procedures, Hysteroscopic Procedures, Dilation and Curettage (D&C), Cervical and Uterine Procedures, Gynecologic Biopsy Procedures, Other Applications 3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Allis Forceps: Curved Allis Forceps, Straight Allis Forceps, Wide Tip Allis Forceps, Narrow Tip Allis Forceps 2) By Artery Forceps: Kelly Artery Forceps, Crile Artery Forceps, Mosquito Artery Forceps 3) By Other Types: Ring Forceps, Foerster Forceps, Tenaculum Forceps, Uterine Dressing Forceps

What Is The Driver Of The Gynecology Surgical Forceps Market?

An increase in the incidence of uterine and vaginal cancer is expected to propel the growth of the gynecology surgical forceps market going forward. Uterine cancer refers to malignancies originating in the uterus, while vaginal cancer pertains to cancers that develop in the vagina, both of which require specialized medical treatment and care. The increase in the incidence of uterine and vaginal cancer is fueled by factors such as aging populations, lifestyle factors such as obesity, which is linked to higher estrogen levels contributing to cancer development. The use of gynecological surgical forceps in uterine and vaginal cancers enhances surgical precision and aids in the effective treatment and management of these conditions, ensuring optimal outcomes for patients undergoing gynecological surgeries. For instance, in January 2023, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, the estimated deaths from uterine cervix cancer in 2022 were 4,280, increasing to 4,310 in 2023, marking a rise of approximately 0.70%. Similarly, deaths from cancers of the vagina and other female genital organs were estimated at 1,630 in 2022 and rose to 1,740 in 2023, representing an increase of about 6.75%. Therefore, an increase in the incidence of uterine and vaginal cancer is driving the gynecology surgical forceps industry.

Key Players In The Global Gynecology Surgical Forceps Market

Major companies operating in the gynecology surgical forceps market are B. Braun Melsungen AG, Aesculap AG, KLS Martin Group, CooperSurgical Inc., MedGyn Products Inc., Sklar Surgical Instruments, Integra LifeSciences, Teleflex Incorporated, Olympus Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, Applied Medical Resources Corporation, CONMED Corporation, Smith and Nephew plc, Stryker Corporation, Medline Industries, Hu-Friedy Group, Novo Surgical Inc., Jarit Surgical Instruments, Stainless Surgical India, Surtex Instruments Limited

Global Gynecology Surgical Forceps Market Trends and Insights

Major companies in the gynecology surgical forceps market are prioritizing innovative product development, including value-driven surgical instruments that offer surgeons reliable quality at accessible prices. For example, in October 2025, gSource, a US-based medical solutions company, launched gSV—a line of more than 260 FDA-registered, ISO 13485-compliant instruments designed to balance high performance with affordability. The collection features both reusable and single-use tools made primarily from German surgical stainless steel and supported by the gSource Lifetime Workmanship Guarantee. This launch underscores the company's commitment to delivering precise, dependable surgical instruments while improving affordability for cost-conscious healthcare professionals.

What Are Latest Mergers And Acquisitions In The Gynecology Surgical Forceps Market?

In July 2023, Marsden Group Limited, a UK-based technology company, was a manufacturer of weighing equipment, weighing scales, medical devices, and patient monitoring systems. Acquired Bailey Instruments Ltd. for an undisclosed amount with this acquisition Marsden Group Limited aims to expand its market presence, diversify its product offerings, enhance research and development capabilities, and leverage synergies to drive future growth in the medical device sector. Bailey Instruments Ltd. is a UK-based manufacturing company that offers precision-crafted gynecology surgical forceps for reliable performance in medical procedure.

Regional Outlook

North America was the largest region in the gynecology surgical forceps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Gynecology Surgical Forceps Market?

The gynecology surgical forceps market consists of sales of products such as tenaculum forceps, foerster sponge forceps, and kocher forceps to assist with gripping, clamping, and manipulating tissues and instruments in various gynecological procedures. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.